Fresenius SE Operating Income 2016-2024 | FSNUY

Fresenius SE annual/quarterly operating income history and growth rate from 2016 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Fresenius SE operating income for the quarter ending June 30, 2024 was $0.284B, a 51.98% decline year-over-year.
  • Fresenius SE operating income for the twelve months ending June 30, 2024 was $0.691B, a 77.14% decline year-over-year.
  • Fresenius SE annual operating income for 2023 was $1.237B, a 64.65% decline from 2022.
  • Fresenius SE annual operating income for 2022 was $3.499B, a 28.87% decline from 2021.
  • Fresenius SE annual operating income for 2021 was $4.919B, a 1.79% decline from 2020.
Fresenius SE Annual Operating Income
(Millions of US $)
2023 $1,237
2022 $3,499
2021 $4,919
2020 $5,009
2019 $5,187
2018 $6,201
2017 $5,187
2016 $4,788
2015 $4,303
Fresenius SE Quarterly Operating Income
(Millions of US $)
2024-06-30 $284
2024-03-31 $607
2023-12-31 $-576
2023-09-30 $377
2023-06-30 $592
2023-03-31 $845
2022-12-31 $694
2022-09-30 $893
2022-06-30 $899
2022-03-31 $1,012
2021-12-31 $1,288
2021-09-30 $1,189
2021-06-30 $1,230
2021-03-31 $1,213
2020-12-31 $1,230
2020-09-30 $1,301
2020-06-30 $1,237
2020-03-31 $1,241
2019-12-31 $1,408
2019-09-30 $1,255
2019-06-30 $1,257
2019-03-31 $1,266
2018-12-31 $1,400
2018-09-30 $1,210
2018-06-30 $2,317
2018-03-31 $1,273
2017-12-31 $1,298
2017-09-30 $1,309
2017-06-30 $1,284
2017-03-31 $1,296
2016-12-31 $1,346
2016-09-30 $1,197
2016-06-30 $1,187
2016-03-31 $1,058
2015-12-31 $7,951
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $20.921B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $17.320B 17.55
DaVita (DVA) United States $12.060B 15.60
Encompass Health (EHC) United States $10.267B 24.21
Chemed (CHE) United States $8.277B 25.44
Elanco Animal Health (ELAN) United States $6.357B 14.29
RadNet (RDNT) United States $5.166B 122.54
Option Care Health (OPCH) United States $3.999B 18.95
Amedisys (AMED) United States $3.199B 22.78
Astrana Health (ASTH) United States $2.920B 41.31
LifeStance Health (LFST) United States $2.728B 0.00
Addus HomeCare (ADUS) United States $2.375B 27.86
U.S Physical Therapy (USPH) United States $1.464B 38.53
Pennant (PNTG) United States $1.004B 46.00
Aveanna Healthcare Holdings (AVAH) United States $0.929B 0.00
Atai Life Sciences (ATAI) Germany $0.198B 0.00
Daxor (DXR) United States $0.047B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.013B 0.00
Ontrak (OTRK) United States $0.007B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00